IDYA
Price
$21.59
Change
-$0.50 (-2.26%)
Updated
Jul 18 closing price
Capitalization
1.89B
22 days until earnings call
TRML
Price
$18.48
Change
-$0.00 (-0.00%)
Updated
Jul 21, 10:42 AM (EDT)
Capitalization
474.72M
Interact to see
Advertisement

IDYA vs TRML

Header iconIDYA vs TRML Comparison
Open Charts IDYA vs TRMLBanner chart's image
IDEAYA Biosciences
Price$21.59
Change-$0.50 (-2.26%)
Volume$549.68K
Capitalization1.89B
Tourmaline Bio
Price$18.48
Change-$0.00 (-0.00%)
Volume$400
Capitalization474.72M
IDYA vs TRML Comparison Chart in %
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. TRML commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and TRML is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (IDYA: $21.59 vs. TRML: $18.48)
Brand notoriety: IDYA and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 50% vs. TRML: 46%
Market capitalization -- IDYA: $1.89B vs. TRML: $474.72M
IDYA [@Biotechnology] is valued at $1.89B. TRML’s [@Biotechnology] market capitalization is $474.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, TRML is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 2 TA indicator(s) are bullish while TRML’s TA Score has 5 bullish TA indicator(s).

  • IDYA’s TA Score: 2 bullish, 6 bearish.
  • TRML’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TRML is a better buy in the short-term than IDYA.

Price Growth

IDYA (@Biotechnology) experienced а -3.96% price change this week, while TRML (@Biotechnology) price change was +2.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.89B) has a higher market cap than TRML($475M). TRML YTD gains are higher at: -8.876 vs. IDYA (-15.992). TRML has higher annual earnings (EBITDA): -98.41M vs. IDYA (-356.46M). IDYA has more cash in the bank: 693M vs. TRML (249M). TRML has less debt than IDYA: TRML (196K) vs IDYA (26M). IDYA has higher revenues than TRML: IDYA (7M) vs TRML (0).
IDYATRMLIDYA / TRML
Capitalization1.89B475M398%
EBITDA-356.46M-98.41M362%
Gain YTD-15.992-8.876180%
P/E RatioN/AN/A-
Revenue7M0-
Total Cash693M249M278%
Total Debt26M196K13,265%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYATRML
RSI
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 4 days ago
71%
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 22 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYHRX40.240.14
+0.35%
Rydex Real Estate H
WBIGX29.720.01
+0.03%
William Blair International Growth N
PGTIX23.93-0.05
-0.21%
T. Rowe Price Global Technology I
MSIQX11.76-0.05
-0.42%
Morgan Stanley Inst International Eq I
BHCFX17.13-0.15
-0.87%
Baron Health Care Retail

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with CGON. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-2.26%
CGON - IDYA
61%
Loosely correlated
N/A
IMNM - IDYA
61%
Loosely correlated
+1.24%
DNLI - IDYA
60%
Loosely correlated
-3.65%
NRIX - IDYA
59%
Loosely correlated
-7.28%
XENE - IDYA
59%
Loosely correlated
N/A
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been loosely correlated with STOK. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TRML jumps, then STOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
-0.65%
STOK - TRML
49%
Loosely correlated
+7.04%
IMNM - TRML
48%
Loosely correlated
+1.24%
IDYA - TRML
45%
Loosely correlated
-2.26%
ANNX - TRML
45%
Loosely correlated
-1.28%
SYRE - TRML
44%
Loosely correlated
-3.55%
More